You are viewing: Rest Of Europe In Vitro Fertilization Market analysis
Part of: In Vitro Fertilization Market (Global)

The Rest Of Europe In Vitro Fertilization Market was valued at $76.7 Million in 2024 and projected to reach to $143.34 Million by 2029, representing a compound annual growth rate of 13.3%. Rest Of Europe's in vitro fertilization market is positioned for sustained growth through 2029, driven by demographic shifts, rising infertility rates, and expanding healthcare accessibility.

Rest Of Europe In Vitro Fertilization Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Europe In Vitro Fertilization Market Trends and Insights

  • This 13.3% compound annual growth rate reflects increasing demand for assisted reproductive technologies across the region.
  • Rest Of Europe is witnessing rising infertility rates, improved healthcare infrastructure, and growing awareness of fertility treatment options, positioning it as a dynamic market segment within the broader European IVF landscape. The growth trajectory in Rest Of Europe is driven by demographic shifts, delayed childbearing, and enhanced access to advanced reproductive technologies.
  • Rest Of Europe's healthcare systems are increasingly integrating IVF services, supported by favorable reimbursement policies in several countries and rising disposable incomes.
  • Between 2024 and 2029, Rest Of Europe is expected to capture significant market share as fertility clinics expand operations and patient acceptance of assisted reproduction continues to strengthen across the region..

Key Market Statistics

  • CAGR (2024-2029) 13.3% CAGR
  • Market Size, 2024 ~USD 76.7 Million
  • Forecast, 2029 ~USD 143.34 Million
  • Country Rest Of Europe

Rest Of Europe In Vitro Fertilization Market Overview

Rapid Market Expansion :

Rest Of Europe's IVF market is growing at 13.3% CAGR, outpacing the global average of 11.7%, driven by increasing infertility prevalence and healthcare modernization across the region.

Significant Revenue Growth :

Market valuation is projected to nearly double from $76.7 million in 2024 to $143.34 million by 2029, reflecting strong demand for assisted reproductive technologies and improved patient accessibility.

Rising Infertility Awareness :

Growing public awareness and reduced stigma surrounding fertility treatments are driving patient demand across Rest Of Europe, supported by improved healthcare infrastructure and clinical capabilities.

Healthcare Infrastructure Development :

Enhanced medical facilities, increased fertility clinic establishments, and better access to advanced reproductive technologies are accelerating market penetration in Rest Of Europe's emerging healthcare markets.

Rest Of Europe In Vitro Fertilization Market Dynamics

  • The region's 13.3% CAGR reflects increasing adoption of assisted reproductive technologies and growing patient awareness of fertility treatment options.
  • Healthcare infrastructure improvements and clinical advancements are enabling broader market reach across smaller European nations. The forecast period will likely see consolidation of fertility clinics, introduction of innovative treatment protocols, and enhanced insurance coverage for IVF procedures.
  • Investment in reproductive medicine education and technology adoption will further strengthen market dynamics.
  • Rest Of Europe's market growth trajectory suggests significant opportunities for healthcare providers, medical device manufacturers, and fertility service operators seeking expansion in underserved European markets..

Related Ecosystem

In Vitro Diagnostics

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Dna Microarrays
  • Assay Kits
  • Microarrays
Top Companies
  • ROCHE HOLDINGS AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Biomerieux s.a.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • CONMED Corporation

      Key Takeaways

      • Rest Of Europe's IVF market is valued at $76.7 million in 2024 and will nearly double to $143.34 million by 2029, representing a 13.3% CAGR.
      • Rest Of Europe is experiencing accelerating demand for assisted reproductive technologies driven by rising infertility rates and delayed childbearing patterns.
      • Rest Of Europe's healthcare infrastructure improvements and favorable reimbursement policies are key enablers of market expansion through 2029.
      • Rest Of Europe represents a high-growth segment within Europe, outpacing global IVF market growth rates and attracting increased clinical investment.

      In Vitro Fertilization Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment FROZEN NON-DONORS (Type)
      Forecast Period 2024-2029
      Growth Rate CAGR of 11.7% from 2024 to 2029
      Largest Segment EQUIPMENT (Product)
      Market Size Base Year (Billions) ~USD 0.95 (2024)
      Revenue Forecast (Billions) ~USD 1.65 (2029)
      Segments Covered Product, Type, Type Of Cycle, Procedure, End User

      Rest Of Europe In Vitro Fertilization Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Product

      • Accessories
      • Anti-Vibration Tables
      • Cabinets
      • Cryosystems
      • Equipment
      • Gas Analyzers
      • Imaging Systems
      • Incubators
      • Laser Systems
      • Micromanipulator Systems
      • Microscopes
      • Other Equipment
      • Ovum Aspiration Pumps
      • Reagents & Media
      • Sperm Analyzer Systems
      • Sperm Separation Systems
      • Witness Systems

      By Type

      • Anti-Vibration Tables
      • Cabinets
      • Cryopreservation Media
      • Cryosystems
      • Embryo Culture Media
      • Gas Analyzers
      • Imaging Systems
      • Incubators
      • Laser Systems
      • Micromanipulator Systems
      • Microscopes
      • Other Equipment
      • Other Incubators
      • Ovum Aspiration Pumps
      • Ovum Processing Media
      • Sperm Analyzer Systems
      • Sperm Processing Media
      • Sperm Separation Systems
      • Time-Lapse Incubators
      • Witness Systems

      By Type Of Cycle

      • Fresh Donors
      • Fresh Non-Donors
      • Frozen Donors
      • Frozen Non-Donors

      By Procedure

      • Conventional Ivf
      • Ivf With Donar Eggs
      • Ivf With Icsi
      • Minimal Ivf
      • Other Procedures

      By End User

      • Cryobanks
      • Fertility Clinics & Ivf Centers
      • Hospitals & Surgical Centers
      • Hospitals & Surgical Clinics
      • Research Institutes

      Target Audience

      • Fertility Clinic Operators : Need market sizing and growth projections for Rest Of Europe to plan clinic expansion, assess profitability potential, and identify underserved geographic areas for new facility development.
      • Medical Device & Pharmaceutical Companies : Require regional market data to evaluate commercial opportunities, forecast demand for IVF equipment and medications, and develop targeted sales strategies for Rest Of Europe's healthcare providers.
      • Healthcare Investment Firms : Seek validated market intelligence on Rest Of Europe's IVF sector to identify acquisition targets, assess portfolio company growth potential, and make informed capital deployment decisions.
      • Healthcare Consultants & Advisors : Need comprehensive market analysis for Rest Of Europe to support client strategy development, competitive benchmarking, and business planning in the reproductive medicine sector.
      • Government & Policy Makers : Require market data on Rest Of Europe's fertility treatment landscape to inform healthcare policy, insurance coverage decisions, and infrastructure investment priorities for reproductive medicine.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise valuation data for Rest Of Europe's IVF market with verified CAGR of 13.3%, enabling accurate financial forecasting and investment decision-making for regional expansion strategies.
      • Competitive Positioning Intelligence : Understand Rest Of Europe's market dynamics relative to global trends, identifying regional opportunities where growth rates exceed international averages and competitive advantages exist.
      • Strategic Market Entry Planning : Access detailed insights into Rest Of Europe's healthcare infrastructure, infertility trends, and patient demand patterns essential for developing targeted market entry and localization strategies.
      • Investment & Funding Decisions : Leverage comprehensive market projections through 2029 to justify capital allocation, secure investor confidence, and prioritize resource deployment across Rest Of Europe's fertility sector.
      • Product Development Alignment : Identify specific regional healthcare needs and treatment gaps in Rest Of Europe to guide R&D priorities, ensuring product offerings match market demand and regulatory requirements.

      Frequently asked questions

      What is the current market size of IVF in Rest Of Europe?

      Rest Of Europe's in vitro fertilization market was valued at $76.7 million in 2024 and is projected to grow to $143.34 million by 2029.

      What is the expected growth rate for Rest Of Europe's IVF market?

      Rest Of Europe's IVF market is expected to grow at a compound annual growth rate (CAGR) of 13.3% from 2024 to 2029.

      What factors are driving IVF market growth in Rest Of Europe?

      Rest Of Europe's IVF market growth is driven by rising infertility rates, delayed childbearing, improved healthcare infrastructure, favorable reimbursement policies, and increased patient awareness of fertility treatment options.

      How does Rest Of Europe's IVF market compare to global trends?

      Rest Of Europe's IVF market is growing faster than the global average, with a 13.3% CAGR compared to the global CAGR of 11.7%, indicating strong regional momentum.

      What is the forecast market size for Rest Of Europe's IVF market in 2029?

      Rest Of Europe's in vitro fertilization market is forecasted to reach $143.34 million by 2029, nearly doubling from its 2024 valuation.

      RESEARCH METHODOLOGY

      In this research, the utilization of both primary and secondary sources was done to a great extent. This included studying the factors affecting the industry to find out the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and strategies by key players.

      Secondary Research

      The secondary research process involves methods using directories, databases such as D&B Hoovers, Bloomberg Businessweek, Factiva, white papers, annual reports, company filings, investor presentations, and SEC filings, and collation of the database of industry leaders. This would help in fleshing out basic information on key players and market segmentation based upon the trends of the industry at various levels, major developments in the market, and technological perspectives pertaining to the in vitro fertilization market.

      Primary Research

      Primary research for this report featured interviews with a cross-section of sources from both the supply and demand sides to generate qualitative and quantitative data. On the supply side, there were primary sources from industries represented by CEOs, vice presidents, marketing and sales directors, regional sales managers, technology and innovation directors, and other key executives from leading companies and organizations in product therapy markets. Primary sources on the demand side included but were not limited to: embryologists, clinicians, procurement managers, purchase managers, department heads, and professionals from hospitals, fertility clinics, in vitro fertilization centers, and reference labs, among others. This primary research was hoped to validate market segmentation, identify key market players, and get an overview of the key trends and dynamics of the industry.

      A breakdown of the primary respondents is provided below:

      In Vitro Fertilization Market Size, and Share

      To know about the assumptions considered for the study, download the pdf brochure

      *Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

      Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1  billion, Tier 2 = <USD 500 million, and Tier 3 = <USD 100 million.

      Market Estimation Methodology

      This report also presents the key players' revenue share analysis for the size of the in vitro fertilization market. The identification of key market participants and insights about their revenues in the in vitro fertilization sector are gathered through phases of primary and secondary research. The secondary research process relied heavily on top players' annual and financial reports, while primary research involved highly exhaustive interviews with key opinion leaders, viz., CEOs, directors, and senior marketing executives.

      The methodology adopted to calculate the global market value was on a segment basis. These segmental revenues were then sourced through the revenue data of major solution and service providers. The steps involved in the process are

      • Draw up a list of key global players operating in the in vitro fertilization market. Map the annual revenues accrued by players from the in vitro fertilization market or nearest reported business unit/ product category.
      • It represents the current major share of the global market as of 2022, using revenue mapping of the key players.

      Extrapolation to the global value for the in vitro fertilization market. Global In vitro fertilization Market: Bottom-Up Approach

      In Vitro Fertilization Market Size, and Share

      To know about the assumptions considered for the study, Request for Free Sample Report

      Global In vitro fertilization Market : Top-Down Approach

      In Vitro Fertilization Market Size, and Share

      In Vitro Fertilization Market Size, and Share

      Data Triangulation

      The in vitro fertilization market was segmented under various categories and subcategories using the above-mentioned methodology. Thereafter, proper data triangulation and the market segmentation process are carried out to further increase the accuracy of the data for each segment. Factors and trends from both the demand and supply sides were studied. Rigorous employment of both top-down and bottom-up approaches provided the result of the analysis of the in vitro fertilization market.

      Market Definition

      The in vitro fertilization market refers to the global landscape of Assisted Reproductive Technologies services and products that help a person or a couple conceive. It is a market that represents fertility clinics, hospitals, and even research institutions that provide in vitro fertilization treatments and related services, including medical devices, laboratory equipment, drugs, and consumables used for in vitro fertilization procedures. It also includes the diagnostic tests carried out prior to and in the course of in vitro fertilization, genetic screening technologies, and cryopreservation services. In vitro fertilization market has been used as a generic term describing the portfolio of diverse technologies, services, and products relating to the alleviation of infertility and the promotion of reproductive health.

      Key Stakeholders

      • Manufacturers and distributors of In vitro fertilization devices
      • Healthcare institutions (Hospitals and clinics)
      • Surgical centers
      • Healthcare institutions (hospitals and cardiac centers)
      • Research institutions
      • Clinical research organizations
      • Academic Medical Centers and Universities
      • Reference labs
      • Clinical research organizations
      • Accountable Care Organizations (ACOs)
      • Research and consulting firms
      • Contract research organizations (CROs) and contract manufacturing organizations (CMOs)
      • Academic medical centers and universities
      • Market research and consulting firms
      • Surgery Centers
      • Group Purchasing Organizations (GPOs)
      • Medical Research Laboratories
      • Academic Medical Centers and Universities

      Objectives of the Study

      • Define, describe, and forecast the In vitro fertilization market on Product, cycle, procedure, end user and region.
      • Analyze opportunities in the market for stakeholders and details of the competitive landscape for market leaders.
      • Detailed information regarding major factors influencing the market growth.
      • Analysis of the micro markets with respect to individual growth trends, prospects, and contribution to the total market.
      • Tracking and analysis of competitive developments such as new product launches and approvals, agreements, partnerships, expansions, acquisitions, and collaborations in the in vitro fertilization market.
      • Description of key companies operating in the market along with their market share analysis and core competencies

      Available Customizations

      With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global In vitro fertilization market

      Product Analysis

      • Product matrix, which gives a detailed comparison of the product portfolios of the top 5 companies.

      Company Information

      • Detailed analysis and profiling of additional market players (up to 5)

      Geographic Analysis

      • Further breakdown of the Rest of Europe's In vitro fertilization market: Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal among other
      • Further breakdown of the Rest of Asia Pacific In vitro fertilization market Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries
      • Further breakdown of the Rest of the world In vitro fertilization market: Latin America, MEA, and Africa

      Get the Full In Vitro Fertilization Market Report

      Full forecast, segment splits, and company analysis for all In Vitro Fertilization Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status